Related Experiment Video
Updated: Jul 3, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
Androgen therapy and atherosclerotic cardiovascular disease
K-C Y McGrath1, L S McRobb, A K Heather
1Heart Research Institute, Camperdown, NSW, Australia.
Abstract:
Cardiovascular disease (CVD) remains the leading cause of death in Western society today. There is a striking gender difference in CVD with men predisposed to earlier onset and more severe disease. Following the recent reevaluation and ongoing debate regarding the estrogen protection hypothesis, and given that androgen use and abuse is increasing in our society, the alternate view that androgens may promote CVD in men is assuming increasing importance. Whether androgens adversely affect CVD in either men or women remains a contentious issue within both the cardiovascular and endocrinological fraternities. This review draws from basic science, animal and clinical studies to outline our current understanding regarding androgen effects on atherosclerosis, the major CVD, and asks where future directions of atherosclerosis-related androgen research may lie.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Aortic Regurgitation III: Medical Management
Coronary Artery Disease I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests